ES2093257T3 - Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales. - Google Patents

Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales.

Info

Publication number
ES2093257T3
ES2093257T3 ES92909055T ES92909055T ES2093257T3 ES 2093257 T3 ES2093257 T3 ES 2093257T3 ES 92909055 T ES92909055 T ES 92909055T ES 92909055 T ES92909055 T ES 92909055T ES 2093257 T3 ES2093257 T3 ES 2093257T3
Authority
ES
Spain
Prior art keywords
torasemide
treatment
preparation
medicines intended
brain edemas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909055T
Other languages
English (en)
Inventor
Tim Boelke
Lothar Kling
Reinhard Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2093257T3 publication Critical patent/ES2093257T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UTILIZACION DE LA TORASEMIDA PARA EL TRATAMIENTO DE EDEMAS CEREBRALES Y TORASEMIDA DE ADMINISTRACION ORAL Y PARENTERAL.
ES92909055T 1991-04-27 1992-04-22 Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales. Expired - Lifetime ES2093257T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4113820A DE4113820A1 (de) 1991-04-27 1991-04-27 Verwendung von torasemid zur behandlung von hirnoedemen

Publications (1)

Publication Number Publication Date
ES2093257T3 true ES2093257T3 (es) 1996-12-16

Family

ID=6430498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909055T Expired - Lifetime ES2093257T3 (es) 1991-04-27 1992-04-22 Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales.

Country Status (8)

Country Link
EP (1) EP0583280B1 (es)
JP (1) JP3429507B2 (es)
AT (1) ATE141053T1 (es)
AU (1) AU1669092A (es)
CA (1) CA2108794C (es)
DE (2) DE4113820A1 (es)
ES (1) ES2093257T3 (es)
WO (1) WO1992019245A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008000737A1 (de) 2008-03-18 2009-09-24 Robert Bosch Gmbh Handwerkzeugmaschine, insbesondere handgeführte Schleifmaschine
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
UA115968C2 (uk) * 2011-03-01 2018-01-25 Фарнекст Нові композиції для лікування неврологічних захворювань
US9867837B2 (en) 2011-03-01 2018-01-16 Pharnext Compositions for treating neurological disorders
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US9931326B2 (en) 2011-03-29 2018-04-03 Pharnext Composition comprising torasemide and baclofen for treating neurological disorders
CN104602682B (zh) 2012-05-08 2018-12-14 埃罗米克斯公司 用于治疗水通道蛋白介导的疾病的化合物
AU2014346682B2 (en) 2013-11-06 2020-03-12 Aeromics, Inc. Novel formulations
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809205D0 (en) * 1988-04-19 1988-05-25 Nye P C G Treatment of oedema

Also Published As

Publication number Publication date
AU1669092A (en) 1992-12-21
CA2108794C (en) 2003-06-24
ATE141053T1 (de) 1996-08-15
CA2108794A1 (en) 1992-10-28
EP0583280A1 (de) 1994-02-23
DE4113820A1 (de) 1992-10-29
EP0583280B1 (de) 1996-08-07
DE59206872D1 (de) 1996-09-12
JP3429507B2 (ja) 2003-07-22
WO1992019245A1 (de) 1992-11-12
JPH06506677A (ja) 1994-07-28

Similar Documents

Publication Publication Date Title
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
HUP9900508A2 (hu) 2-Amino-4-(4-fluor-benzil-amino)-1-(etoxi-karbonil-amino)-benzol alkalmazása agyi vérellátási zavarok, valamint neurodegeneratív megbetegedések következményeinek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
BR9306226A (pt) Composiçao de cura de feridas e tratamento de distúrbios fibróticos e método para a sua preparaçao
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
ES2082887T3 (es) Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
BR9407293A (pt) Efeitos neutoprotetores primários e secundários do flupirtino nas doenças neurodegenerativas
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE59206872D1 (de) Verwendung von torasemid zur behandlung von hirnödemen
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
NO951995D0 (no) Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner
NO178252C (no) Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
MX9200841A (es) Proceso mejorado para la preparacion de dinitrotolueno.
EP0667157A4 (en) AGENT FOR TREATING CYCLING COMPLAINTS.
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
FI873727A7 (fi) Terebraaliseen iskemiaaseen liittyvien häiriöiden hoitoon tarkoitettu terapeuttinen aine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 583280

Country of ref document: ES